October 6, 2008
DIRECTOR'S UPDATE- ACS Institutional Research Grants
The Case Comprehensive Cancer Center is pleased to announce the successful competition of the American Cancer Society Institutional Research Grant (IRG), resulting in four awards to Cancer Center faculty members. Junior faculty with clear independent research were eligible to apply for these awards. After careful scientific review of the 14 applications received, the review committee, chaired by Dr. Ed Stavnezer, identified four awards to be funded. Each funded project demonstrated outstanding potential to evolve into an NCI-funded application within the next 3 years.
The awardees are:
These investigators will be asked to present their results either at the Cancer Center retreat, or at an upcoming retreat focused on all of the pilot grants awards of the past 2 years.
Congratulations to all.
Please note: The Cancer Center will be issuing another call for IRG projects in March 2009. Be sure to watch the newsletter and our website for the RFA.
Stan Gerson, MD
NCI AWARDS–Avon Foundation; caBIG
The Case Comprehensive Cancer Center has received two awards from the NCI to promote our cancer research efforts:
I. Joe Baar, MD, Associate Professor of Medicine, Ireland Cancer Center and CWRU, and member of the Breast Cancer Clinical Trials Team, received the "Progress for Patients" award for his grant, MUC1 and Poly-ICLC Vaccine for Triple-Negative Breast Cancer. This highly competitive award is part of a program co-sponsored by the NCI along with funds from the Avon Foundation to promote innovative clinical trials research in breast cancer. Funds will be used to initiate the first breast cancer vaccine trial in high risk patients using the MUC1 antigen. Dr. Baar and his colleagues have identified that this antigen is expressed on breast cancer cells and that the MUC1 antigen can invoke an immune response. The trial will assess immunologic response, tolerance and time to recurrence.
II. The Case CCC has been awarded funding to implement tools developed for the biomedical information systems that support cancer research. The Cancer Biomedical Informatics Grid (caBIG) tools support clinical trials, imaging, tissue banking, and integrative cancer research. The award partially supports a staff member to assess and prepare the cancer center to implement appropriate caBIG tools. For more information on this award, please click here.
NEW MEMBERS CORNER
Please join us in welcoming the following new members of the Case CCC:
Helene Bernstein, MD, PhD
Mukesh Jain, MD
Ofer Reizes, PhD
FUNDING OPPORTUNITY– Landon Foundation-AACR Innovator Awards
The Landon Foundation and AACR have paired up to offer the following opportunities in cancer research:
Landon Foundation-AACR Innovator Award for Cancer Prevention Research
Landon Foundation-AACR Innovator Award for International Collaboration
Deadline for both awards is November 20
FUNDING OPPORTUNITY– Prostate Cancer Foundation Creativity Awards
The Prostate Cancer Foundation (PCF) is pleased to announce a funding mechanism for supporting transformational prostate cancer research through development of creative research ideas with high potential and no current funding. We seek applications from individuals proposing high-risk/high-reward concepts that if successful, could provide the basis for dramatically reducing death and suffering from prostate cancer. Creativity awards are intended to bridge the gap between an idea and the results necessary to justify longer term and more significant funding.
High priority for funding will be given to exceptional proposals that bring NEW research methods and techniques in life, physical, or computational sciences to solving the prostate cancer problem that have not previously been directed against prostate cancer. Applicants who have not historically worked in prostate cancer, but are proposing creative hypotheses and research plans for our field, are highly encouraged to apply. Originality and novelty will be rewarded in the peer review process. Potentially high impact basic science programs will be considered with high priority given to exceptional proposals that have the potential to be translated towards clinical investigations or provide "proof of principle".
Deadline: November 21
For details, please click here.
FUNDING OPPORTUNITY– ACS MEN2 Thyroid Cancer Professorship
The American Cancer Society (ACS) is currently accepting applications for the ACS MEN2 Thyroid Cancer Consortium Professorship. The Consortium will be led by a single renowned senior scientist who will be awarded the American Cancer Society MEN2 Thyroid Cancer Professorship and act as leader for the overall program. Appropriate areas of investigation include, but are not limited to: understanding consequences of RET mutations, molecular events underlying the development of MEN2-related tumors, improved animal models of MEN2, new screening and monitoring tools, new imaging approaches, and new pharmacologic and other strategies to blunt the effects of RET mutations.
This award is intended for an outstanding mid-career investigator who has made a seminal contribution and who continues to provide leadership in this general research area. Applications are requested from distinguished investigators in an area that includes multiple endocrine neoplasia type 2 research, including research in the areas of genetics, pathogenesis, diagnosis or treatment of medullary thyroid cancer.
Application Deadline: December 15
For details, please click here.
**All events are open to anyone interested in attending
Hematology/Oncology Research In Progress Seminar
Pathology Research Seminar Series
Physiology & Biophysics Seminar
Skeletal Research Center Seminar
Taussig Cancer Center Core Curriculum Series
Taussig Cancer Institute Core Curriculum Series
Practice-Based Research Network Seminar
Hematology/Oncology Fellows Seminar
Taussig Cancer Institute Grand Rounds
Cell Biology Seminar
MARK YOUR CALENDARS:
UPCOMING CANCER CENTER SYMPOSIUMS
**For more information on these symposiums, please contact Christine Rhoads.
Head and Neck Conference
FUNDING OPPORTUNITY– Chemical Biology Consortium
NCI, through its Operations and Technical Support Prime Contractor SAIC-Frederick, Inc., is seeking input and ideas from the scientific community and the biotechnology and pharmaceutical sector about an innovative initiative that will bridge the gap between basic scientific findings and NCI-supported clinical research and in the process establish the NCI as a leader in he area of innovative cancer therapeutics discovery.
The RFI addresses the feasibility of establishing an integrated network of chemical biologists, molecular oncologists, and screening centers from government, industry, and academia with specific drug development skills and expertise to address unmet needs in therapeutic oncology. NCI is calling this network the Chemical Biology Consortium (CBC). The response to this RFI will be used to assess the feasibility of assembling a consortium of experts to participate in the NCI's new Drug Discovery and Development Platform, whose mission is to advance first-in-class, targeted molecular therapeutic agents to the clinic. CBC-related activities will span the entire spectrum from target identification and validation through proof-of-concept (POC) Phase I/II clinical trials. Project Teams will be formed with Project Team Leaders tasked with coordinating the discovery and development of novel cancer therapeutics in an environment that fosters open cooperation and communication.
Deadline: October 27
For more information, please click here.
FUNDING OPPORTUNITY– Susan G. Komen for the Cure Postdoctoral Fellowships
Susan G. Komen for the Cure has extended the Postdoctoral Fellowship pre-application deadline. Postdoctoral Fellowships seek to attract pre-faculty scientists into breast cancer by providing up to $60,000 annually over three years. Fellows develop skills and expertise in one of two research tracks, basic and translational research leading to reductions in breast cancer incidence and/or mortality. Pre-applications are required prior to starting a full application. To view the RFA, please click here.
Pre-application Deadline: October 17
CALL FOR NOMINATIONS– AACR Future Leaders Symposium
The AACR Associate Member Council seeks institutional nominations of outstanding and innovative young investigators as speakers for the third annual Future Leaders Special Symposium to be held during the AACR 100th Annual Meeting, April 18-22, 2009 in Denver, CO. This is an unprecedented opportunity, during the world's largest meeting for cancer researchers, to showcase how your institution is contributing to the future of cancer research!
Each institution may submit two nominations, but the nominees must represent different areas of cancer research (e.g., laboratory, clinical, or translational research, epidemiology, etc.).
If you would like to nominate someone for this opportunity, please contact Gillian Irwin (email@example.com) by Wednesday, October 15.
For details, please click here.
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
World Cancer Research Fund International
NIH Bulletin – Notices and Funding Opportunities
11100 Euclid Avenue, Wearn 152
Cleveland, Ohio 44106-5065
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
|If you have trouble viewing this page, click here to view the newsletter online on our website.|